CA-125 |
|
|
CA-125, which stands for cancer antigen 125, is a tumor marker or biomarker that may be elevated in the blood of some people certain cancers. CA-125, a product of the MUC16 gene, and is most commonly thought of as being a marker for ovarian cancer, but it may also be elevated in other cancers, such as endometrial cancer, cancer of the fallopian tubes, lung cancer, breast cancer, and cancer of the gastrointestinal tract. It may also be elevated with a number of benign conditions, such as endo ...
Wikipedia - [full article]
CA-125 Clinical Trials
- Stem Cell Transplantation for Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00001880 - Recruiting
Cholangiocarcinoma; Colon/Rectal Ca; Bladder Ca; Breast Ca; Basal Cell Ca; Adrenal Ca; Esophageal/Gastric Ca; Hepatocellular Ca; Ovarian Ca; ...
- Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
ClinicalTrials.gov Identifier: NCT00539162 - Recruiting
Ovarian Cancer
- Computed Tomography and Serum CA-125 in Patients With Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00502151 - Recruiting
Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
- CA 125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00058032 - Active, not recruiting
ovarian epithelial cancer
- CA-125 in Screening Patients at High Risk for Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00080639 - Active, not recruiting
ovarian epithelial cancer
- Removal of the ovaries/fallopian tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
ClinicalTrials.gov Identifier: NCT00043472 - Recruiting
Ovarian Neoplasms; Breast Neoplasms
- CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
ClinicalTrials.gov Identifier: NCT00305838 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Screening Study of Surgery and CA 125 Levels in Participants at Increased Genetic Risk of Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00049049 - Active, not recruiting
ovarian epithelial cancer
- Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00002895 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA
ClinicalTrials.gov Identifier: NCT00535795 - Active, not recruiting
Nasopharyngeal CA
- Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults
ClinicalTrials.gov Identifier: NCT00110279 - Active, not recruiting
Influenza; Virus Diseases
- Effect of Roflumilast on Exacerbation Rate in Patients With COPD: The HERMES Study (BY217/M2-125)
ClinicalTrials.gov Identifier: NCT00297115 - Active, not recruiting
Chronic Obstructive Pulmonary Disease (COPD)
- TMC 125 Blood Levels Study
ClinicalTrials.gov Identifier: NCT00531323 - Recruiting
HIV Infections
- I-125 Versus Pd-103 for Low Risk Prostate Cancer
ClinicalTrials.gov Identifier: NCT00494039 - Active, not recruiting
Prostate Cancer
- Comparison of Two Types of Biopsy in Patients With Breast Lesions That Cannot Be Felt Upon Examination
ClinicalTrials.gov Identifier: NCT00006031 - Active, not recruiting
Breast Cancer
- Hormonal Ablation, Imatinib & Docetaxel Followed by Radical Prostatectomy for High-Risk Localized Prostate Ca.
ClinicalTrials.gov Identifier: NCT00500110 - Active, not recruiting
Prostate Cancer
- Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 Seeds
ClinicalTrials.gov Identifier: NCT00348465 - Recruiting
Prostate Cancer
- I-125 Versus Pd-103 for Medium Risk Prostate Cancer
ClinicalTrials.gov Identifier: NCT00486499 - Recruiting
Prostate Cancer
- Pilot Trial of Pre-Operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA
ClinicalTrials.gov Identifier: NCT00535041 - Active, not recruiting
Rectal Neoplasms
- Molecular Profiling Protocol (SCRI-CA-001)
ClinicalTrials.gov Identifier: NCT00530192 - Recruiting
Refractory Cancer
- Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
ClinicalTrials.gov Identifier: NCT00346372 - Recruiting
Ocular Melanoma
- Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA
ClinicalTrials.gov Identifier: NCT00534729 - Active, not recruiting
Laryngeal Neoplasms; Hypopharyngeal Neoplasms
- Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial
ClinicalTrials.gov Identifier: NCT00247312 - Recruiting
Prostatic Neoplasm
- A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection
ClinicalTrials.gov Identifier: NCT00560599 - Recruiting
Methicillin Resistant Staphylococcus Aureus Skin Infections
- Luteal v. Follicular Phase Surgical Oophorectomy & Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor + Br. CA
ClinicalTrials.gov Identifier: NCT00293540 - Recruiting
Breast Cancer
- Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic CA
ClinicalTrials.gov Identifier: NCT00547144 - Recruiting
Pancreatic Cancer
- Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients
ClinicalTrials.gov Identifier: NCT00563173 - Recruiting
Chronic Hepatitis C Virus Infection
- QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
ClinicalTrials.gov Identifier: NCT00568425 - Recruiting
Anal Cancer
- Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 y) (BY9010/CA-101)
ClinicalTrials.gov Identifier: NCT00163293 - Recruiting
Asthma
- Depo-Provera: Evaluation of BMDensity and Total Body Ca Adolescent DP150CI Users and Non-Hormonal Contraception
ClinicalTrials.gov Identifier: NCT00139685 - Active, not recruiting
Contraception; Bone Density
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-Based P Binders in Patients With Hyperphosphatemia
ClinicalTrials.gov Identifier: NCT00451295 - Recruiting
Chronic Kidney Disease; Dialysis; Hyperphosphatemia
- A Randomized, Controlled Study on Ca Blocker Vs. AII Antagonists in Hypertension with Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00144144 - Active, not recruiting
Hypertension; Diabetes Mellitus, Type 2
- Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults. The ACCEPT-Study. (BY9010/CA-102)
ClinicalTrials.gov Identifier: NCT00404547 - Recruiting
Asthma
- TPF+Radiation+/-Cetuximab in Larynx CA/ DeLOS II
ClinicalTrials.gov Identifier: NCT00508664 - Recruiting
Squamous Cell Carcinoma of the Hypopharynx; Larynx Carcinoma
- Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma
ClinicalTrials.gov Identifier: NCT00079417 - Recruiting
intraocular retinoblastoma
- Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA
ClinicalTrials.gov Identifier: NCT00373711 - Recruiting
Thyroid Cancer
- Comparison of Cephalexin Versus Clindamycin for Empiric Treatment of Suspected CA-MRSA Skin Infections
ClinicalTrials.gov Identifier: NCT00352612 - Recruiting
Staphylococcal Infection; Abscess; Staphylococcal Skin Infection; Folliculitis
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00063882 - Recruiting
stage II prostate cancer; adenocarcinoma of the prostate
- Use of ACA 125 in Patients with Ovarian Cancer: Safety and Immune Response
ClinicalTrials.gov Identifier: NCT00103545 - Completed
Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms
- Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00107172 - Recruiting
stage I non-small cell lung cancer
- Randomized Study of Sildenafil Citrate During & After Radiotherapy for Erectile Ftn Vs Radiotherapy for Prostate Ca
ClinicalTrials.gov Identifier: NCT00142506 - Recruiting
Prostate Cancer
- Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)
ClinicalTrials.gov Identifier: NCT00546520 - Completed
Asthma
- Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
ClinicalTrials.gov Identifier: NCT00354965 - Completed
Sinusitis, Acute Bacterial
- Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma
ClinicalTrials.gov Identifier: NCT00003876 - Completed
recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult brain stem glioma; ...
- EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI
ClinicalTrials.gov Identifier: NCT00394368 - Completed
Bronchial Asthma
- ResQ Trial: Impact of an Impedance Threshold Device and Active Compression Decompression CPR on Survival from Out-of-Hospital Cardiac Arrest
ClinicalTrials.gov Identifier: NCT00189423 - Recruiting
Heart Arrest; Death, Sudden, Cardiac; Cardiopulmonary Resuscitation
- Effects of Roaccutane on Ca, P, PTH and Vitamin D Metabolites in the Treatment of Sever Acne
ClinicalTrials.gov Identifier: NCT00416585 - Completed
Acne
- Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)
ClinicalTrials.gov Identifier: NCT00209404 - Completed
Coronary Artery Disease
- A Randomized, Double-Blind, Placebo-Controlled Trial with 0.75mg Pramipexole (BI•Sifrol®) Orally Once Daily to Investigate the Efficacy and Safety for 6 Weeks in Patients with Primary Restless Legs Syndrome.
ClinicalTrials.gov Identifier: NCT00152997 - Completed
Restless Legs Syndrome
- A Double-Blind, Placebo-Controlled, Randomised Withdrawal Study of 3 Month Duration in Patients Suffering from Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-Month Treatment with Open-Label Pramipexole Including Titration (0.125, 0.25,
ClinicalTrials.gov Identifier: NCT00152958 - Completed
Restless Legs Syndrome
- A Randomized, Double-Blind, Placebo-Controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 Mg, 0.25 Mg, 0.5 Mg and 1.0 Mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients with Motor F
ClinicalTrials.gov Identifier: NCT00148512 - Completed
Parkinson Disease
- A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
ClinicalTrials.gov Identifier: NCT00053378 - Completed
Hypocalcemia
- Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors
ClinicalTrials.gov Identifier: NCT00003574 - Completed
recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult glioblastoma multiforme; adult anaplastic astrocytoma
- External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006365 - Completed
stage II prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Brachytherapy in Treating Patients With Recurrent Malignant Glioma
ClinicalTrials.gov Identifier: NCT00045474 - Completed
adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult glioblastoma; recurrent adult brain tumor
- Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00032006 - Completed
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
- Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
ClinicalTrials.gov Identifier: NCT00073710 - Completed
Secondary Hyperparathyroidism; Chronic Kidney Disease
- Stage IV Colorectal CA ALIMTA
ClinicalTrials.gov Identifier: NCT00166465 - Suspended
Locally Advanced Unresectable or Stage IV Colorectal Cancer
- First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients
ClinicalTrials.gov Identifier: NCT00251186 - Terminated
Colorectal Cancer

Not Signed In -


